THALIDOMIDE
2001; Elsevier BV; Volume: 19; Issue: 1 Linguagem: Inglês
10.1016/s0733-8635(05)70232-1
ISSN1558-0520
Autores Tópico(s)Autoimmune Bullous Skin Diseases
ResumoThalidomide has been successful in the treatment of several dermatologic conditions unresponsive to other agents. Further experience may lead to a better understanding of its mechanism of action in these various diseases. Thalidomide should be considered an extremely valuable therapeutic option in selected patients when the benefits clearly outweigh the risks of teratogenicity and peripheral neuropathy.
Referência(s)